Literature DB >> 798592

[Treatment of irritable colon. A multicenter placebo-controlled double-blind study in general practice].

V W Rahlfs, P Mössinger.   

Abstract

The effect of Asa foetida (0.1% alcoholic dilution) and a combination of Asa foetida and Nux vomica (0.01% alcoholic dilution) was tested in a multicenter placebo-controlled double-blind trial. Both groups with active medication differed trivially but showed a marked superiority to the placebo group. The differences, however, just miss the conventional 5%-level of statistical significance. For the interpretation of this result it must be considered that only about half of the total of patients could be reached who in the planning phase of the study had been regarded necessary for a statistical confirmation of a therapeutic effect. The diagnosis "Colon irritabile" is discussed in its historical context and the psychological structure of the patient sample is described by means of the scores of a standard personal inventory test (FPI). The trial shows that it is possible to obtain objective results on the basis of the patients' judgment (rating scales with low information content).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 798592

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  The comprehensiveness of Medline and Embase computer searches. Searches for controlled trials of homoeopathy, ascorbic acid for common cold and ginkgo biloba for cerebral insufficiency and intermittent claudication.

Authors:  J Kleijnen; P Knipschild
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

2.  Clinical trials of homoeopathy.

Authors:  J Kleijnen; P Knipschild; G ter Riet
Journal:  BMJ       Date:  1991-02-09

3.  Homeopathy for treatment of irritable bowel syndrome.

Authors:  Emily J Peckham; Katy Cooper; E Rachel Roberts; Anurag Agrawal; Sally Brabyn; Garry Tew
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

4.  A protocol for a trial of homeopathic treatment for irritable bowel syndrome.

Authors:  Emily J Peckham; Clare Relton; Jackie Raw; Clare Walters; Kate Thomas; Christine Smith
Journal:  BMC Complement Altern Med       Date:  2012-11-06       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.